References
1. Jazi K, Rahimi M, Hasani F, Shirmohammadi M, Masoumi M. Scleritis Following the booster shot of inactivated COVID-19 (Sinopharm) Vaccine in a 52-year-old Woman. Authorea. 2023.
2. Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, Stepp HE, Clements TP. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. Febs j. 2020;287(17):3633-50.
3. Vitiello A, Ferrara F, Troiano V, La Porta R. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology. 2021;29(5):1357-60.
4. Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, Ivanovska M, Makka SA, Hashem F, Marquez L, Cseprekal O, Filgueiras IS, Fonseca DLM, Mickael E, Ling I, Arero AG, Cuschieri S, Minakova K, Rodríguez-Román E, Abarikwu SO, Faten AB, Grancini G, Cabral-Marques O, Rezaei N. COVID-19 vaccinations: The unknowns, challenges, and hopes. J Med Virol. 2022;94(4):1336-49.
5. Guo W, Deguise J, Tian Y, Huang PC-E, Goru R, Yang Q, Peng S, Zhang L, Zhao L, Xie J, He Y. Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports. Frontiers in Pharmacology. 2022;13.
6. Yeh L-Y, Chang C-Y, Chang R, Wei JC-C. COVID-19 vaccine triggers autoimmune disease? Possible mechanism and current evidence. International Journal of Rheumatic Diseases. 2024;27(1):e14963.
7. Wang MTM, Niederer RL, McGhee CNJ, Danesh-Meyer HV. COVID-19 Vaccination and The Eye. Am J Ophthalmol. 2022;240:79-98.
8. Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi. JAMA Ophthalmol. 2021;139(10):1131-5.
9. Moorthy RS, Moorthy MS, Cunningham ET, Jr. Drug-induced uveitis. Curr Opin Ophthalmol. 2018;29(6):588-603.
10. Ng XL, Betzler BK, Ng S, Chee SP, Rajamani L, Singhal A, Rousselot A, Pavesio CE, Gupta V, de Smet MD, Agrawal R. The Eye of the Storm: COVID-19 Vaccination and the Eye. Ophthalmology and Therapy. 2022;11(1):81-100.
11. Peyman A, Pourazizi M, Dehghani S, Ghorbani S. Recurring nodular scleritis following inactivated vaccination for COVID‐19. Clinical Case Reports. 2023;11(6).
12. Parmar UP, Surico PL, Singh RB, Musa M, Scarabosio A, Surico G, Maniaci A, Lavalle S, D’Esposito F, Longo A, Russo A, Gagliano C, Zeppieri M. Ocular Implications of COVID-19 Infection and Vaccine-Related Adverse Events. Journal of Personalized Medicine [Internet]. 2024; 14(8).
14. Testi I, Brandão-de-Resende C, Agrawal R, Pavesio C. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12(1):4.
15. Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi. JAMA Ophthalmology. 2021;139(10):1131-5.
16. Hurissi EA, Abuallut II, Dibaji MQ, Jaly A, Alhazmi AH, Abuageelah BM, Alameer KM, Alyami YM. Ocular Complications after COVID-19 Vaccination: A Systematic Review. Medicina [Internet]. 2024; 60(2).
17. Mahendradas P, Mishra SB, Sangoram R, Srinivasan S, Kawali A, Patil A, Shetty R. Ocular manifestations following COVID-19 vaccination. Journal of Ophthalmic Inflammation and Infection. 2023;13(1):44.
18. Fenoglio R, Lalloni S, Marchisio M, Oddone V, De Simone E, Del Vecchio G, Sciascia S, Roccatello D. New onset biopsy-proven nephropathies after COVID vaccination. American journal of nephrology. 2022;53(4):325-30.
19. Safary A, Esalatmanesh K, Eftekharsadat AT, Nakjavani M-RJ, Khabbazi A. Autoimmune inflammatory rheumatic diseases post-COVID‐19 vaccination. International immunopharmacology. 2022;110:109061.
20. Londoño M-C, Gratacós-Ginès J, Sáez-Peñataro J. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination–still casualty? Journal of hepatology. 2021;75(5):1248-9.
21. Cunningham ET, Jr., Moorthy RS, Fraunfelder FW, Zierhut M. Vaccine-Associated Uveitis. Ocul Immunol Inflamm. 2019;27(4):517-20.
22. Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cellular & molecular immunology. 2018;15(6):586-94.
23. Kanduc D, Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunologic research. 2020;68(5):310-3.
24. Otaif W, Al Somali AI, Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report. Am J Ophthalmol Case Rep. 2020;20:100917.
25. Li SY, Chen HH, Liu PY, Shi ZY, Lin YH, Tsai CA, Lin SP. Case report of acute encephalitis following the AstraZeneca COVID‐19 vaccine. International Journal of Rheumatic Diseases. 2022;25(8):950-6.
26. Moni SS, Abdelwahab SI, Jabeen A, Elmobark ME, Aqaili D, Ghoal G, Oraibi B, Farasani AM, Jerah AA, Alnajai MMA, Mohammad Alowayni AMH. Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines (Basel). 2023;11(11).
27. Manzo G. COVID-19 as an immune complex hypersensitivity in antigen excess conditions: theoretical pathogenetic process and suggestions for potential therapeutic interventions. Frontiers in Immunology. 2020;11:566000.
28. Papasavvas I, Herbort CP, Jr. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect. 2021;11(1):21.
29. Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following Vaccination for COVID-19. Ocul Immunol Inflamm. 2021;29(4):741-2.
30. Pan L, Zhang Y, Cui Y, Wu X. Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. Int J Infect Dis. 2021;113:116-8.
31. Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021;23:101136.
32. Reshef ER, Freitag SK, Lee NG. Orbital Inflammation Following COVID-19 Vaccination. Ophthalmic Plast Reconstr Surg. 2022;38(3):e67-e70.
33. Turner JS, O'Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, Lei T, Thapa M, Chen RE, Case JB, Amanat F, Rauseo AM, Haile A, Xie X, Klebert MK, Suessen T, Middleton WD, Shi PY, Krammer F, Teefey SA, Diamond MS, Presti RM, Ellebedy AH. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021;596(7870):109-13.
34. Rahmani A, Dini G, Montecucco A, Orsi A, Sticchi L, Domnich A, Bruzzone B, Pellegrini L, Manca A, Ogliastro M, Kusznir Vitturi B, Zacconi S, Debarbieri N, Icardi G, Durando P. Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy. Vaccines (Basel). 2022;10(11).